Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
The CYP19A1 rs700519 Polymorphism and Breast Cancer Susceptibility in China: A Case–Control Study and Updated Meta-Analysis Genetic Testing and Molecular Biomarkers (IF1.795), Pub Date : 2021-07-19, DOI: 10.1089/gtmb.2021.0032 Fei Lv, Wanying Huang, Ying Wang
Objective: Breast cancer (BC), the most prevalent cancer in women, has been associated with several genetic factors, including the CYP19A1 rs700519 polymorphism; however, the conclusions have not been consistent. This case–control study and meta-analysis aimed to further assess the relationship between the CYP19A1 rs700519 polymorphism and BC susceptibility.